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Repression of Puma by Scratch2 is required for
neuronal survival during embryonic development
E Rodrı´guez-Aznar1 and MA Nieto*,1
Although Snail factors promote cell survival in development and cancer, the tumor-suppressor p53 promotes apoptosis in
response to stress. p53 and Snail2 act antagonistically to regulate p53 upregulated modulator of apoptosis (Puma) and cell death
in hematopoietic progenitors following DNA damage. Here, we show that this relationship is conserved in the developing
nervous system in which Snail genes are excluded from vertebrate neurons and they are substituted by Scratch, a related but
independent neural-specific factor. The transcription of scratch2 is induced directly by p53 after DNA damage to repress puma,
thereby antagonizing p53-mediated apoptosis. In addition, we show that scratch2 is required for newly differentiated neurons to
survive by maintaining Puma levels low during normal embryonic development in the absence of damage. scratch2 knockdown
in zebrafish embryos leads to neuronal death through the activation of the intrinsic and extrinsic apoptotic pathways.
To compensate for neuronal loss, the proliferation of neuronal precursors increases in scratch2-deficient embryos, reminiscent
of the activation of progenitor/stem cell proliferation after damage-induced apoptosis. Our data indicate that the regulatory loop
linking p53/Puma with Scratch is active in the vertebrate nervous system, not only controlling cell death in response to damage
but also during normal embryonic development.
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When activated by cellular stress, p53 acts as a crucial tumor
suppressor, acting through a very intricate signaling network
involving multiple positive and negative regulatory feedback
loops.1 Indeed, its activity is modulated by its own transcrip-
tional targets, p53 upregulatedmodulator of apoptosis (Puma)
and murine double minute gene 2 (Mdm2), which transduce
the apoptotic response or trigger p53 degradation, respec-
tively.2 Accordingly, irreparable damage results in apoptosis,
whereas mild stress may elicit a p53 survival response
associated with DNA repair.3 Hence, the effects of p53 are
defined by its affinity for response elements (REs) in different
target genes, the cell context and the nature and duration of
the stress signal.
Scratch and Snail are transcriptional repressors from
independent gene families that originated by duplication of
the ancestral snail gene.4 They are prominently expressed
during embryonic development, occupying complementary
territories in vertebrates. As such, Snail genes are expressed
in mesodermal and mesenchymal cells,5 whereas Scratch
family members are neural specific.6,7 Although Snail factors
have received much attention in cancer research and
developmental biology,8 the functional analyses of scratch
genes in vivo are scarce9,10 and still missing in vertebrates.
AlthoughSnail factors drive the conversion of epithelial cells
to migratory cells,8 scratch genes are excluded from epithelial
and mesenchymal cells, which makes them unlikely to
participate in epithelial–mesenchymal transition. However,
members of the Snail family11,12 and the Caenorhabditis
elegans Scratch homolog, cell death specification 1 (ces-1),
have been implicated in conferring resistance to cell death.10
Expression of theC. elegans puma homolog, egl-1 (egg laying
defective 1), is repressed by ces-1,13 and Puma is the main
effector of p53-induced cell death in vertebrates.2 Indeed,
Snail2 can antagonize p53-mediated apoptosis by repressing
Puma in hematopoietic precursors following DNA damage.12
The only Snail-like sequence found in the C. elegans
genome is thought to encode a non-functional protein.4
Hence, we wondered whether ces-1, the sole Scratch
homolog, had co-opted the role of Snail in repressing Puma
in the nematode. Alternatively, Puma repression might be an
ancestral function associated to both snail and scratch genes
before their divergence. Therefore, we investigated the role of
Scratch in vertebrate cell survival using zebrafish, a suitable
model to study cell death and p53 signaling.14–16 We charac-
terized three zebrafish scratch genes that were specifically
expressed in the nervous system and we found that scratch2
acts as a survival factor in neurons in vivo. We show that
scratch2 is directly upregulated by p53 and that it represses
puma transcription after DNA damage. More importantly, we
show that scratch2 protects neurons from apoptosis by
maintaining Puma levels low during normal embryonic
development.
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Results
Expression of zebrafish scratch genes. Two Scratch
genes exist in vertebrates, Scratch1 and Scratch2, and
although an extra genome duplication gave rise to additional
genes in the teleost lineage,17 only two scratch1 (scratch1a
and 1b) and one scratch2 genes make up the scratch family
in zebrafish.4 We obtained the three full-coding regions of
zebrafish scratch genes that encode Scratch proteins
with strong similarity to those predicted from other teleosts
(Supplementary Figure 1) and vertebrates (Supplementary
Figure 2). The three sequences contain the diagnostic
Scratch domains: five Scratch-type C2H2 zinc-fingers and
the Scratch and Snail1/GFI domains.18
The scratch1 genes were first expressed at the 21 somite
stage in the developing central nervous system of zebrafish
embryos (Figures 1a and d). Although scratch1a transcripts
were detected in the telencephalic dorsorostral cluster19 (drc)
and hindbrain (h, Figure 1a), scratch1b was most strongly
expressed in the hindbrain and diencephalic ventrocaudal
cluster19 (vcc, Figure 1d). At 24 hours post-fertilization (h.p.f.),
the expression of both genes was better defined in the same
regions (Figures 1b and e). Similarly, scratch2was expressed
in both the drc and vcc, and in the hindbrain at the same
stages, and at 24 h.p.f., it was also strongly expressed in the
spinal cord (sc, Figures 1g–i), which was devoid of scratch1a
and 1b transcripts (Figure 1c and f). scratch2 transcripts were
detected in the spinal cord from the onset of its expression at
the six-somite stage (Figure 1m), when it was also expressed
in sensory Rohon-Beard neurons and in the placode of the
trigeminal ganglion (tg, Figures 1j and k). However, this spinal
cord expression was dynamic and transient, with no tran-
scripts detected after 36 h.p.f. (data not shown). At 24 h.p.f.,
scratch2 transcripts were evident in the mantle layer of the
spinal cord at different dorsoventral levels (Figure 1l) and not
in the ventricular zone, indicating that it is expressed where
postmitotic neurons are found. Hence, like the Drosophila,9
C. elegans10 and mouse scratch16,7 and scratch27 homologs,
the three zebrafish scratch genes are restricted to the nervous
system, with scratch2 being expressed in the same territories
as the two scratch1 genes, and in the spinal cord at the time
of neuronal differentiation.
scratch2 knockdown induces cell death in the spinal
cord. To study the function of scratch genes, we examined
the effects of disrupting scratch2 activity in the spinal cord,
which only expresses this scratch gene. Two morpholino
oligonucleotides, one that overlapped the start codon (MO1)
and another against the 50 UTR (MO2, see Supplementary
Figure 3), were injected into one-cell embryos. The survival
of the embryos injected with MO1 was 86% (7 ng) and 70%
(15ng), whereas up to 84% (2 ng) and 50% (7 ng) of embryos
survived when injected with MO2 (n4150 embryos per
condition). Similar survival (84%) was evident after injection
of a control morpholino (MOC), which did not produce any
detectable phenotype at the concentrations used. In contrast,
both MO1 and MO2 induced dose-dependent shortening
of the embryos and opacity, characteristic of cell death at
24 h.p.f. (Figure 2a). At concentrations that produced similar
embryo survival and opacity, injection of both MO’s (7 ng of
MO1 or 2 ng of MO2 per embryo) increased apoptosis in
94% of the embryos, when compared with the control
MO (n¼ 100; Figure 2b). Although distributed throughout
the embryo (Supplementary Figure 3), the injected
morpholinos should only affect regions that express target
genes, and, indeed, apoptosis only increased in the nervous
system. This cell death did not appear to be an off-target
effect of morpholino injection (as described for around 20%
of sequences20) because both MOs produced the same
effect. Moreover, there was no morphological phenotype or
additional apoptosis in injected embryos analyzed at the
six-somite stage when scratch2 expression commences
(Figure 2b). Indeed, when we co-injected MO2 (directed
against the 50 UTR sequences) with an mRNA containing
the coding region of scratch2, morpholino-induced apop-
tosis was fully rescued in up to 85% of embryos (n¼ 100;
Figures 3g–i), reflecting the specificity of this effect. Hence,
scratch2 might act as an anti-apoptotic factor in developing
zebrafish embryos, although endogenous embryonic apop-
tosis persisted (Figures 3h and i) and scratch2 overexpres-
sion did not impede the endogenous cell death in the spinal
cord (Figures 3j–l) and trigeminal ganglion (n¼ 8 ganglia
per condition) in which it is prominent at these stages
(Supplementary Figure 4).
scratch2 interacts with the p53 pathway to protect
from cell death. As cell death augments in the developing
spinal cord of scracth2 morphants, we wanted to deter-
mine the molecular pathway by which Scratch2 regulates
apoptosis. Members of the p53 family are critical elements in
the apoptotic program, p53 being the key family member
in the zebrafish nervous system.21 An increase in p53 activity
is associated with considerable apoptosis in the nervous
system and growth arrest in embryos,14 a phenotype reminis-
cent to that observed in the scratch2 morphants. Hence, we
assessed whether scratch2 and p53 might be acting in the
same pathway. Injection of p53 MO alone did not induce any
embryonic defects (98%, n¼ 100; Figures 3m–o) as expected,
as p53 is not essential for zebrafish (or mouse) embryonic
development.14 Indeed, when MOs against scratch2 and
p53 were co-injected into embryos, they were indistingui-
shable from control embryos (91%, n¼ 77; Figures 3p–r).
Hence, it appears that Scratch2 protects neurons from
apoptosis and that the death induced by Scratch2
downregulation is mediated by p53.
As Snail/Scratch proteins are transcriptional repressors,4
we assessed whether Scratch2 could protect cells from
apoptosis by repressing p53 transcription. There were no
significant changes in p53 expression in scratch2 morphant
embryos (Figure 4a), indicating that Scratch2 does not act
directly upstream of p53. However, Scratch2 downregulation
activates p53, as it influences the expression of its main
direct target, mdm2 (Figure 4a). Conversely, we determined
whether activating p53 with camptothecin (CPT), an anti-
cancer drug that promotes p53-mediated apoptosis in
zebrafish, affects scratch2.14 CPT induced DNA damage
and large-scale apoptosis in the spinal cord of 98% of
embryos (n¼ 100), which was impaired by injecting p53 MO
(75%; n¼ 100). Hence, the apoptosis induced by CPT was
mediated by p53 and it was concomitant with increased
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Figure 1 Expression of scratch genes in zebrafish embryos. The expression of scratch1a, scracth1b and scratch2 was analyzed at different developmental stages. (a–c)
scratch1a is first expressed in the telencephalon and the hindbrain of 21-somite embryos, and this pattern is better appreciated at 24 h.p.f. (d–f) The onset of scratch1b
expression is similar to that of scratch1a, although the expression in the hindbrain is more prominent and transcripts can also be detected in the diencepahalon. (g–i) scratch2
is prominently expressed in the regions of scratch1a and 1b expression and in the spinal cord.(j and k). scratch2 is expressed in the precursors of the trigeminal ganglion and
in the sensory Rohon-Beard neurons from the six-somite stage (lateral and dorsal views, respectively). (l) scratch2 expression in the spinal cord at 24 h.p.f. is restricted to the
mantle layer at all dorsoventral levels. (m) RT-PCR confirms the onset of scratch2 expression in six-somite stage embryo. h, hindbrain; n, notochord; drc, telencephalic
dorsorostral cluster; RB, Rohon-Beard neurons; sc, spinal cord; tg, precursors of the trigeminal ganglion; vcc, diencephalic ventrocaudal cluster
Scratch2 represses Puma during neural development
E Rodrı´guez-Aznar and MA Nieto
1198
Cell Death and Differentiation
p53 transcription (Figures 4b and c). Upregulation of direct
transcriptional targets of p53, mdm2 and the BH3-only puma
further confirmed the functional activation of p53 (Figure 4c).
Moreover, scratch2 transcription was also upregulated in
CPT-treated embryos (Figure 4c), augmenting the number of
cells expressing scratch2 in the spinal cord by 55% in
a p53-dependent manner (from around 11 to 17 per somite
in three independent embryos per condition, Figure 4d).
The complement of cells expressing scratch2 was normal
in p53-morphant embryos, indicating that p53 is not the
MOC scrt2MO1 scrt2MO2
MOC-7ng MO1-7ng
24
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f. MO2-2ng
scrt2MO2MOC scrt2MO1 MOC
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Figure 2 scrtach2 knockdown induced cell death in zebrafish embryos at 24 h.p.f. (a) Two different morpholino antisense oligonucleotides were designed against adjacent
sequences in the 50 region of scratch2. scratch2 morpholino injections produced shortening and opacity, as assessed by morphology in embryos at 24 h.p.f. (b) A significant
increase in cell death in the spinal cord was detected by TUNEL staining. Pictures show flat-mounted embryos highlighting dorsal views of the spinal cord. No morphological
defects or significant cell death could be observed in embryos injected with control morpholino (MOC) or with scratch2 MOs analyzed as whole embryos at the six-somite stage
(6s), when endogenous scratch2 begins to be expressed (anterior is to the left)
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endogenous inducer of scratch2. These results demonstrate
that scratch2 is a novel p53 target activated after DNA
damage.
scratch2, a new direct target of p53. To determine
whether p53 directly activates scratch2 transcription, we
looked for putative p53-responsive elements in the scratch2
gene with the p53MH algorithm.22 We identified two putative
p53-binding sites for which luciferase reporter constructs
were generated, one in the 50 UTR and another in the
scratch2 intronic sequences (Figure 5a). A similar construct
containing the p53 RE in puma was used as a positive
control.12 The constructs were independently injected into
one-cell zebrafish embryos and p53 was activated by treating
the zebrafish embryos with CPT at the 21-somite stage. This
activation of p53 transactivated each scratch2 reporter, and
as this transactivation was prevented when p53 was knocked
down, p53 appears to activate scratch2 transcription through
the putative binding sites identified (Figure 5b). Moreover, in
chromatin immunoprecipitation assays (ChIP) performed on
embryos treated with CPT, p53 was specifically recruited
to fragments containing the binding site in the scratch2
promoter (Figure 5c) and, hence, we consider scratch2 to be
a novel direct target of p53.
Scratch2 directly represses puma transcription. As
scratch2 knockdown did not affect p53 transcription
(Figure 4) and Snail/Scratch factors act as transcriptional
repressors, Scratch2 could repress the transcription of pro-
apoptotic genes downstream of p53. Hence, we assessed
puma expression when Scratch2 function was compromised,
one of the main mediators of apoptosis in the nervous system.
Injection of MO2 strongly upregulated puma expression in
zebrafish embryos at 24h.p.f., an effect that was prevented by
co-injection with p53 MO (Figures 6a and b). Thus, this
increase in puma transcription appears to be mediated by p53,
explaining the rescue of cell death observed when p53 MO
was co-injected with scratch2 MO (Figures 3p–r). These data
also support that Scratch2 could repress puma transcription.
Similar to Snail, Scratch binds to E-boxes, and in murine
hematopoietic cells, Snail2 has already been shown to bind to
a consensus E-box in an intron of Puma.12 Indeed, we found
two putative Scratch-binding sites in the first intron of zebrafish
puma. As antibodies against Scratch are not available, we
scrt2MO2WT scrt2MO2+mRNA scrt2MO2+p53MOp53MOscrt2 mRNA
TU
NE
L
Figure 3 scratch2 protects from cell death by antagonizing the p53 pathway. Embryos at 24 h.p.f. were subjected to TUNEL staining and shown as whole embryos, flat
mounts or in transverse sections through the spinal cord. (a–i). The cell death phenotype observed after scratch2 MO injection could be rescued by co-injection of scratch2
mRNA. (j–l) Injection of scratch2 mRNA alone does not protect from endogenous cell death. (m–o) p53 morphant embryos are indistinguishable from control embryos. (p–r)
The co-injection of p53 MO prevents the death induced by scratch2 MO
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generated a myc-tagged Scratch2 fusion protein to perform
ChIP assays. Moreover, as scratch2 overexpression is
insufficient to protect against endogenous apoptosis
(Figure 3), the ChiP experiment was performed in a
scratch2-morphant background that can be rescued by
injection of scratch2 mRNA (Figure 3). As expected,
co-injection of scratch2 MO and myc-scratch2 mRNA
prevented the apoptosis induced by scratch2 knockdown
(75%, n¼ 40; Figure 6c). Under these conditions, Scratch2
can bind to a fragment containing the first E-box in the puma
intron (Figure 6d), demonstrating that Scratch2 can directly
repress puma transcription, preventing embryonic cell death in
the absence of damage.
scratch2 downregulation activates intrinsic and
extrinsic apoptotic pathways. In the scratch2-morphant
embryos studied here, apoptotic cells appeared in regions
of endogenous scratch2 expression and in adjacent cells
extending two or three cell layers, indicative of a non-cell-
autonomous phenotype (Figures 3f and 7c). These apoptotic
cells appear to account for about one-third of the total
terminal deoxynuclotidyl transferase (TdT)-mediated dUTP
nick end labelling (TUNEL)-positive cells. As this ectopic
cell death was prevented by co-injection of scratch2 mRNA,
it was considered a specific consequence of scratch2
knockdown. As a transcription factor, Scratch2 should act
in a cell-autonomous manner and, thus, scratch2 MO should
only produce effects in cells that normally express this factor.
Nevertheless, these cells could produce non-cell-auto-
nomous effects by activating an extrinsic apoptotic path-
way. Accordingly, overexpression of a specific inhibitor of the
extrinsic pathway (FLICE-inhibitory protein (FLIP))23 should
block the apoptosis observed outside the endogenous
domain of scratch2 expression. Injection of flip mRNA
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Figure 4 p53 activation induces scratch2 expression in the spinal cord. (a) Scratch2 does not regulate p53 transcription. Real-time RT-PCR from embryos injected with
control (MOC), scratch2, p53 or scratch2 plus p53 MOs. The transcription of p53 is not affected by scratch2 knockdown, but its transcriptional activity, measured by the levels
of its readout mdm2, is increased. (b) Flat-mounted spinal cords from 24 h.p.f. embryos showing the apoptosis induced by camptothecin (CPT)-mediated p53 activation.14
(c) Real-time RT-PCR to assess the transcription of p53, its targets puma and mdm2 and of scratch2 in embryos subjected to the treatments shown in b. scratch2 transcription
is activated in response to CPT treatment. (d) scratch2 is activated in ectopic spinal cord cells on CPT treatment in a p53-dependent manner. Real-time RT-PCR data in a are
means±S.E.M. of five independent experiments and c shows a representative experiment (n¼ 3), with each point examined in triplicate in all cases. *Po0.05: **Po0.01
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alone did not affect embryos, which were indistinguishable
from controls (96%, n¼ 30: Figures 7a, b and e), whereas
there were fewer apoptotic cells in embryos co-injected
with flip mRNA and scratch2 MO than when scratch2
was knocked down (89% n¼ 37; compare Figure 7c with f).
Interestingly, the remaining apoptotic cells were only found
in the mantle layer of these embryos, within the limits of
the endogenous scratch2 expression domain (compare
Figures 7d with f). Hence, scratch2 knockdown leads to
cell-autonomous activation of the intrinsic apoptotic pathway
in cells that normally express scratch2, subsequently
inducing cell death in adjacent cells through an extrinsic
apoptotic pathway.15 Indeed, B-cell lymphoma 2 (bcl2) over-
expression completely abolished the apoptotic phenotype
in 75% of embryos co-injected with scratch2 MO (n¼ 65;
Figure 7h), both in endogenous territories of scratch2
expression and in adjacent cells.
The apoptosis in the scratch2morphants did not significantly
reduce the size of the spinal cord, perhaps because
compensatory proliferation can be triggered in adjacent cells,
as inDrosophila andmice.24–26 Indeed, the apoptosis observed
in scratch2morphants was followed by an increase inmitosis in
the ventricular zone, assessed by phosphohistone 3 (pH3)
staining (Figures 7i–l). This increased proliferation was
specifically related to scratch2 knockdown, as the normal
number of mitotic cells were observed when the morpholino
was co-injected with scratch2mRNA (Figures 7k and l). Hence,
the apoptosis induced by loss of Scratch2 is associated with
compensatory proliferation that attempts to heal the tissue.
Discussion
By characterizing the zebrafish scratch genes, we show that,
similar to their homologs in other species, they are specifically
expressed in the nervous system during early develop-
ment.6,7,9,10 The three scratch genes are expressed in
overlapping and specific patterns in the developing brain
and scratch2 alone is expressed in the embryonic spinal cord.
This specific expression of scratch2 allowed us to analyze
vertebrate Scratch function in vivo for the first time, avoiding
the problems of compensation due to co-expression of
multiple family members. Accordingly, we pinpoint a role for
Scratch in neuron survival during normal embryonic develop-
ment, repressing Puma expression in the absence of DNA
damage.
Scratch2 promotes neuronal survival by suppressing
Puma expression during normal development. The
induction of Puma expression by stress can provoke
indiscriminate death of mature cells, whereas in deregu-
lated systems (e.g., tumors), the loss of Puma may be
sufficient to overcome apoptosis.27 Thus, maintaining Puma
levels low is essential for cell survival. Snail2 can protect
hematopoietic progenitor cells from cell death induced by
DNA damage by repressing Puma transcription.12 In the
nervous system, scratch2 knockdown de-represses puma
and provokes neuronal death, even in the absence of DNA
damage. This indicates that Scratch2 is required for neuron
survival during normal development, and that Puma must be
actively repressed, even in the absence of stress signals.
Newly differentiated spinal cord neurons need an effective
way to repress Puma activity to survive, and this can be
achieved during embryonic development through Scratch2
(Figure 8a).
The knockdown of scratch2 augments puma expression
and neuronal death in a p53-dependent manner (Figure 8b),
even though p53 expression remains unaffected. As p53 is
constitutively transcribed during development, its activity is
tightly regulated through proteasomal degradation triggered
by its own target, Mdm2,28 and by its sequestration by anti-
apoptotic members of the Bcl-2 family.29 Puma is a common
target of p53 and Scratch2 for activation or repression,
respectively. Indeed, Scratch2 binds to an E-box located very
close to the p53 consensus RE in a puma intron, suggesting
that they might compete for binding, as previously postulated
for Snail2.30 In the absence of damage, low levels of p53
enable Scratch2 to bind to the intron of puma and prevent its
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ATG(+1)
5 ´UTR Intron
-439 +1133
Luc
Lucpuma
scrt2
+
-
-
-
-
+
+
+
--
+
-
-
-
+
*
*
*Luc
+
-
-
+
+
0
puma
scrt2 5’ UTR
scrt2 Intron
12108642
Figure 5 scratch2 transcription is directly activated by p53. (a) p53-binding
sites in scrtach2. Putative p53 response elements are found in the promoter and
within the intron of scratch2 sequences (gray boxes, positions relative to the ATG).
(b) Luciferase assays carried out in whole zebrafish embryos. CPT-mediated
p53 activation correlates with reporter activity for puma-positive control constructs
and scratch2 constructs containing p53-binding sites found either in the promoter or
in the intron. Transactivation is prevented by the co-injection of p53 MO. *Po0.05
(c) Chromatin immunoprecipitation assays (ChIP) in embryos treated with CPT
(see Materials and Methods). Input material was tested for each primer set. ChIP
analyses were carried out with anti-p53 antibodies on 24 h.p.f. zebrafish embryos
amplifying the p53 response element in puma intron as a positive control for
immunoprecipitation. H3 and IgG are the positive and negative controls of the
immunoprecipitate, respectively; C- is a PCR negative control. The data presented
are representative of three independent experiments
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transcription (Figure 8a). Conversely, p53 can activate
puma transcription in the absence of Scratch2 (Figure 8b).
Interestingly, the p53/Bcl-XL equilibrium is disrupted by
Puma, releasing p53 into the cytoplasm.31 Thus, newly
expressed Puma may augment the p53 cytoplasmic pool,
reinforcing Puma expression and cell death.
After DNA damage, p53 activation directly increases
scratch2 transcription in the zebrafish, establishing a negative
feedback loop similar to that described for Mdm2, but through
direct repression of Puma rather than p53 degradation
(Figure 8c). Similarly, p53 upregulates the transcription of
other prosurvival genes, including Snail family members.12
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Figure 7 scratch2 downregulation activates both the intrinsic and extrinsic apoptotic pathways in the spinal cord, concomitant with compensatory proliferation. Embryos at
24 h.p.f. were TUNEL stained (a–c and e–h) or subjected to in situ hybridization for scratch2 (d), and transverse sections through the spinal cord are shown. (a–d) After
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scratch2 MO. (i–l) pH3 immunoreactivity and cell quantification reveals that cell death in scratch2 morphants induce compensatory proliferation in the ventricular zone
(compare j with i, and l). Co-injection of scratch2 MO and mRNA rescues this phenotype (k and l). **Po0.01
Figure 8 Role of Scratch2 in neuron survival during development. (a) In the wild-type embryo, Scratch2 maintains puma transcription repressed, allowing neuronal
differentiation and survival. (b) Scratch2 downregulation de-represses puma, permitting p53 binding to its response element in the intron and resulting in neuronal cell death.
Apoptosis mediated by the intrinsic pathway in these cells induces the extrinsic apoptotic program in the neighboring cells. Dying cells induce progenitor cells in the ventricular
zone to increase proliferation in an attempt to compensate for cell loss. (c) On DNA damage, p53 induces the transcription of several target genes, including mdm2, puma and
scratch2. p53 protein levels are controlled by degradation induced by Mdm2. Cells expressing high levels of Scratch2 can interfere with the p53 apoptotic program through the
repression of puma, leading to cell survival. A long-lasting or strong damage induces apoptosis as the final outcome of persistent p53 activity
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Weak Scratch expression permits Puma transcription,
whereas strong Scratch expression would prevent p53 from
acting on Puma, probably by interfering with the assembly of
the transcriptional complex.
Scratch2 is required for newly differentiated neurons
to survive: evolutionary considerations. Evolution has
favored the need for Scratch to promote neuron survival.
Increased scratch (ces-1) expression in C. elegans leads to
the appearance of supernumerary neurons, although it is
not, in principle, required for neuron survival.32 However,
scratch2 knockdown in zebrafish is sufficient to promote
neuronal death, while its overexpression does not promote
the survival of additional neurons, which also seems to
be true in the chick embryo (our unpublished results).
Interestingly, vertebrate evolution has implemented robust
mechanisms to regulate cell number and to eliminate super-
numerary neurons,33 which suggests the need for a system
ensuring controlled neuronal survival. Although in tissues
with little proliferation, mature cells need to be protected,
mature cells are dispensable in those with high proliferation
rates, as long as there are sufficient progenitors.12 For
example, the progenitors in the hematopoietic system
express Snail2 and, hence, they are protected from
p53-induced cell death after DNA damage.12 Other adult
tissues have poor proliferative capacity and they must protect
mature cells, as also seems to be the case in the developing
nervous system in which differentiated neurons express
scratch to protect them from cell death.
The role of Scratch2 in the survival of zebrafish and
C. elegans neurons (refs. 10, 13 and data herein) indicates
that resistance to cell death is an ancestral function
associated with the Scratch superfamily. Snail proteins have
also been implicated in promoting cell survival on different
apoptotic stimuli,8,11 indicating that cell survival is an ancestral
function associated with both families before diploblasts and
bilateria diverged.4 Accordingly, the better-known role of Snail
factors in regulating cell adhesion and movement was
probably co-opted later by Snail genes alone. It is intriguing
that evolutionary patterns also show that p53 genes existed
before the appearance of cancer.34 Therefore, the crucial
tumor suppressor functions associated with this family were
not ancestral but rather, similar to Snail and Scratch, the
ancestral function appears to be the regulation of cell death,
which existed even before the regulation of the cell cycle.35
Whether the Snail, Scratch and p53 families evolved hand-in-
hand to establish the p53 regulatory networks during evolution
might be an interesting topic to explore in the future.
Scratch2 downregulation, activation of intrinsic and
extrinsic apoptotic pathways and compensatory
proliferation. During embryonic development, puma is
activated after scratch2 knockdown to stimulate the mito-
chondrial apoptotic pathway in the zebrafish neural tube.
Scratch2 deficiency provokes cell-autonomous death of
differentiated neurons that otherwise express scratch2.
Similarly, it activates non-autonomous cell death through
an extrinsic apoptotic pathway in progenitor cells that do
not normally express scratch2, revealing a role for the
extrinsic apoptotic pathway in the zebrafish nervous
system15 (Figure 8b). Similar cell death of both proliferative
and differentiated cells occurs in the intestine of young mice
deficient for Mdm2.26 Interestingly, fish and mice respond
similarly to the loss of a p53-induced negative regulator,
Scratch2 or Mdm2, not only in terms of cell death but also
by inducing compensatory proliferation (ref. 26 and data
herein) Indeed, although the apoptosis induced by Scratch2
downregulation could reduce the size of the spinal cord,
increased proliferation of neural progenitors in the ventricular
zone appears to prevent this from occurring. Hence, this
tissue seems to activate mechanisms to overcome neuronal
loss and maintain tissue homeostasis, similar to the
compensatory mechanisms described in Drosophila.24,25
The apoptosis and compensatory proliferation observed in
our scratch2 morphants, is reminiscent of the massive
leukocyte cell death and compensatory proliferation, which
repopulates damaged tissue following irradiation of wild-
type mice and which leads to secondary malignancies
appearing because of the damage to progenitor/stem
cell pools.36,37 Conversely, the lack of cell death and of
subsequent compensatory proliferation in Puma-deficient
mice protects them from developing secondary tumors.36,37
In summary, although both p53 and Puma seem to be
dispensable for normal embryonic development, they can
respond rapidly to damage; thus, inhibitors must be available
to tightly control their activity. Here, we describe one such
inhibitor, Scratch2, which acts directly on the main readout
of p53 signaling, puma. When scratch2 is downregulated,
puma levels increase, promoting neuronal cell death by
activating both intrinsic and extrinsic apoptotic pathways even
in the absence of DNA damage. Neuronal loss activates
compensatory progenitor cell proliferation, a physiological
mechanism at play during development to maintain tissue
homeostasis, which may be corrupted in circumstances of
previous DNA damage, to provoke the appearance of cancer.
Materials and Methods
Fish maintenance. AB and Tup-Lof wild-type Zebrafish strains maintained at
281C under standard conditions were used in all experiments. The embryos were
staged, as indicated elsewhere.38
Isolation of zebrafish cDNAs. Total RNA was extracted with Trizol
(Invitrogen, Paisley, UK) from 24-h.p.f. zebrafish embryos and used to synthesize
cDNA using SuperScript III reverse transcriptase (Invitrogen) and oligodT as a
primer. Subsequent PCR amplification was carried out using primers directed to
the 50- and 30 UTR sequences as follows: scratch1a: 50-ATGGATCCGGATAA
CGTGCTGGAAGAGG-30and 30-AATCTAGAGAAGTCACGCCTCAATGGAC-50;
scratch1b: 50-CGGGATCCCGGACGAGTGTTTTCTCCTT-30 and 30-GCTCT
AGATGCGATTAATCCTCGGTGTT-50; scratch2: 50-GGATCCTCTGTGCGACCG
TGAACC-30 and 30-GCCTCGAGGGATTTTTGCGAGCATTAAA-50. Amplified
fragments were subcloned into pTOPO and pCS2þ . Zebrafish actin was
amplified as a control for scratch2 expression during developmental stages with the
following primers: 50-CTGGTTGTTGACAACGGATCCG-30 and 50-CAGACTCA
TCGTACTCCTGCTTGC-30. Zebrafish puma (DQ860151), flip (NM_194399) and
bcl2 (ENSDART00000105690) coding sequences were amplified with the following
sets of oligonucleotide primers: puma, 50-CACGATTCTGGGATAACATCAA-30 and
50-ACCCGTGTGTTCATCTGAGG-30; flip, 50-GGATCCGGTGAAATGGCAGATGG
ATT-30 and 50-GGATCCGGAGTGGTTTGTGTTGTGTTG-30; bcl2, 50-GGAT
CCGCGCGTTTCTATCGTGATTT-30 and 50-TCTAGAGAGGCTGTCACTTCTGAGC
A-30. In all cases, sequences represent forward and reverse primers, respectively. The
puma DNA fragments were subcloned into the pGEM.TE plasmid and those from
flip and bcl2 into the pCS2þ plasmid. Myc-tagged scratch2 was subcloned in
pCS2þ -NLS-MT (kindly provided by JL Go´mez-Skarmeta) after amplification with
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the following primers: Forward 50-GAATTCCATGCCTCGCTCGTTTCT-30 and
reverse, 50-CTCGAGTTAATTCTCTGAGCCAGATTCG-30.
Morpholino oligonucleotides and mRNA injections. All morpholino
antisense oligonucleotides were obtained from Gene Tools LLC (Philomath, OR,
USA) and used as described by Nasevicius and Ekker.39 Two antisense morpholinos
(MOs) were used. MO1, 50-GAGGCATGGTTCACGGTCGCACAGA-30, overlapping
the start codon and injected from 2 to 15 ng per embryo, and MO2, 50-CGCACC
AGAAAATCCTTCACATCGG-30, located at the 50 UTR and injected from 1 to 7 ng
per embryo (Supplementary Figure 3). The sequence of p53 MO was described
previously.20 The standard control morpholino from Gene Tools was used for control
injections. All oligonucleotides were injected into the yolk of one- or two-cell embryos
using a pressure injector (PicoSpritzer, Parker, Fairfield, NJ, USA). MO1 was
fluoresceinated to confirm that the morpholino was distributed to all cells after injection
and during embryo development (Supplementary Figure 4).
For rescue and overexpression experiments, mRNA was synthesized
and capped using the mMessage mMachine Kit (Ambion, Austin, TX, USA).
Rescue analyses were performed with 75 pg per embryo of scratch2 mRNA lacking
the 50 UTR region to which MO2 binds. For overexpression analyses, 75–100 pg per
embryo of myc-scratch2, flip and control RNAs or 200 pg per embryo of bcl2 mRNA
were used.
In situ hybridization and immunohistochemistry. In situ hybridization
and immunohistochemistry of whole-mount zebrafish embryos for scratch2, puma
and pH3 (Rabbit anti-pH3 antibody, 1:1000, Upstate Biotechnology, Lake Placid,
NY, USA) were performed as described previously.40 Embryos were then fixed and
embedded in gelatin to obtain vibratome sections (30 mm). Embryos were
photographed using an Olympus DP70 digital camera (Olympus, Hamburg,
Germany) on either a Leica M10 dissecting microscope or a Leica DMR microscope
(Leica, Wetzlar, Germany). Flat-mounted 24-h.p.f. embryo spinal cords are shown
anterior-up, unless otherwise indicated.
Quantitative reverse transcription PCR. Quantitative reverse transcrip-
tion PCR was performed using the Step One Plus (Applied Biosystems, Carlsbad,
CA, USA) sequence detection system and the SYBR Green method (Applied
Biosystems). The data show one representative experiment. Statistics correspond
to n¼ 3 unless otherwise indicated, with each point examined in triplicate.
Transcript levels were calculated using the comparative Ct method normalized
to GAPDH. The final results were expressed relative to the control condition using
the 2(DDCt)±S.D. formula. The primers used are listed below:
Gapdh (AY818346), 50-GCAGAAAAGCCAGACCATTC-30 and 50-CTCGTAGGT
GGGAACAGGAA-30; scrt2, 50-ACTACGAGTCGGCCTGCTT-30 and 50-GGGATTT
TTGCGAGCATTAAA-30; puma (DQ860151), 50-ACGCTGTCTTCCTTCAGAGG-30
and 50-GGTAGAGGGCATTGATGGTG-30; p53 (DRU60804), 50-CAGTCTGGCACA
GCAAAATC-30 and 50-ATTTGAACGGGGCAAGTTTT-30; and mdm2 (AF356346),
50-ATTGTTCACGGAAGGACTGG-30 and 50-CCACTGACTGAATGGGCTCT-30.
CPT treatment and TUNEL assay. CPT (Calbiochem) treatment was
performed as described.14 A 50mM stock of CPT in DMSO was diluted in Danieau’s
buffer to obtain a 500 nM working solution that was applied to 21-somite stage
embryos at 281C until the stage of analysis (24 h.p.f.). Embryos used for luciferase
assays and ChIP experiments were treated with CPT for the first 2 h and kept in
embryo medium until they reached 24 h.p.f. Control embryos were mock treated
with Danieau’s buffer containing the same concentration of DMSO. Apoptosis was
analyzed with the TUNEL kit (Roche, Basel, Switzerland) according to
manufacturer’s instructions.
Cell quantification. For the analyses of scrt2- and pH3-positive cells, 30mm
consecutive sections corresponding to five consecutive somites (s5–s9) were
analyzed in embryos at 24 h.p.f. Quantification of TUNEL-positive cells in trigeminal
ganglia was carried out in flat-mounted 24 h.p.f. embryos. At least three embryos
were counted per condition and marker (n¼ 3 for scrt2, n¼ 6 for pH3 and n¼ 8 for
trigeminal ganglia).
Luciferase assays. The p53MH algorithm22 was used to identify putative p53
REs present in scratch2 and puma genomic sequences. To generate the luciferase
reporter plasmids, various fragments containing the p53 putative REs were sub-
cloned in pGL3Basic (Promega, Madison, WI, USA). PCR amplification was
performed on adult zebrafish genomic DNA as template with the following sets of
oligonucleotide primers:
scrt2 50 UTR, 50-CATCATGGTACCTGATCTCACTCCCACCGT-30 and 50-CATC
ATGCTAGCTCAGCACTGGATAGCTCC-30; scrt2 intron, 50-CATCATGCTAGCTC
CCACCTGTTACGAAAA-30 and 50-CATCATCTCGAGTGATGCTTAAACCATTCAT-30;
and puma intron, 50-CATCATACGCGTTGCATTAATTTCTGACAAGT-30 and 50-CATC
ATCCCGGGACCAGCGACAGGCTAT-30.
Luciferase assays were performed as previously described.41 Briefly, the
reporter plasmid of the firefly luciferase gene, under the control of the different
p53 REs obtained for scratch2 (12.5 pg per embryo) and puma (2.5 pg per embryo),
was injected into one-cell stage zebrafish embryos, together with 1.25 pg per
embryo of a plasmid containing the Renilla luciferase gene under the control of the
Tk promoter. The 21-somite stage embryos were treated with 500 nM CPT for 2 h to
promote p53 activation and the embryos were then kept in embryo medium for
2 more hours. Subsequently, 20 embryos of each experimental condition were
lysed in 100ml lysis buffer (Passive lysis buffer, Promega) and assays were carried
out on 10ml of the embryo lysate with a Dual-Luciferase Reporter Assay System
(Promega). The data are represented as the mean±S.D. of three different
experiments.
Chromatin immunoprecipitation. ChIP experiments were carried out
following the Upstate cell signaling solutions protocol (Upstate cell signaling
solutions, Billerica, MA, USA). Briefly, embryos were treated with CPT (see above)
and then 30 embryos were sonicated in 300ml lysis buffer per condition in each
experiment. The chromatin was immunoprecipitated with the anti-p53 antibodies,
kindly provided by Professor G Del Sal (University of Trieste, Trieste, Italy) and goat
anti-myc (Abcam, Cambridge, UK). The antibodies used as negative and positive
controls were Rabbit anti-IgG (Diagenode, Lie`ge, Belgium) and Rabbit anti-H3
(Abcam), respectively. The oligonucleotide primers used for PCR detection were:
scrt2 50 UTR, 50-TGATCTCACTCCCACCGT-30 and 50-CTCAGCACTGGATA
GCTCC-30; scrt2 intron, 50-TCCCACCTGTTACGAAAA-30 and 50-TGATGC
TTAAACCATTCAT-30; puma p53 RE and E-box1, 50-TGCATTAATTTCTGA
CAAGT-30 and 50-ACCAGCGACAGGCTATCAA-30; puma E-box2, 50-TCTG
CTGACACTCCTCCTCA-30 and 50-GCAACAGCCTGAGCTGAAAT-30. The data
presented are representative of three independent experiments.
Database search. NCBI and EMBL-EBI/WellcomeTrust Sanger Institute
databases were searched through the BLAST family of programs (http://www.ncbi.
nlm.nih.gov/BLAST) and http://www.ensembl.org, respectively. Sequence alignments
were carried out using Clustal W (http://www.ebi.ac.uk/clustalw; ref. 42) and corrected
by visual inspection.
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